(Q45474964)

English

Interferon combined with cyclosporine treatment as an effective countermeasure against hepatitis C virus recurrence in liver transplant patients with end-stage hepatitis C virus related disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Interferon combined with cyclosporine treatment as an effective countermeasure against hepatitis C virus recurrence in liver transplant patients with end-stage hepatitis C virus related disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Inoue K

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Yoshiba M

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

1 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1233-1234

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Long-term outcome of hepatitis C virus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.11.041

7 January 2021

Predictors of patient and graft survival following liver transplantation for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.11.041

7 January 2021

Combined interferon alpha2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.11.041

7 January 2021

Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.11.041

7 January 2021

A pilot study of the combination of cyclosporin A and interferon alfacon-1 for the treatment of hepatitis C in previous nonresponder patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.11.041

7 January 2021

C2 monitoring of cyclosporine in de novo liver transplant recipients: the clinician's perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.11.041

7 January 2021

Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.11.041

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2004.11.041

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45474964&oldid=2076974543"